Last update 26 May 2025

EN3285

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
EN-3285
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsMouth and Tooth DiseasesOther Diseases
Active Indication-
Inactive Indication
Squamous cell carcinoma of the oral cavityStomatitis
Originator Organization
Elan Corp.Elan Corp.
Active Organization-
Inactive Organization
Endo Pharmaceuticals, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with EN3285
EUCTR2007-006549-42-GB
/ Not yet recruitingPhase 3
A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of EN3285 for the Prevention or Delay to Onset of Severe Oral Mucositis in Subjects with Head and Neck Cancer Receiving Chemoradiotherapy - N/A
NCT00574860
/ TerminatedPhase 3
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo- Controlled Study to Assess the Efficacy and Safety of EN3285 for the Prevention or Delay to Onset of Severe Oral Mucositis in Patients With Head and Neck Cancer Receiving Chemoradiotherapy
100 Clinical Results associated with EN3285
Login to view more data
100 Translational Medicine associated with EN3285
Login to view more data
100 Patents (Medical) associated with EN3285
Login to view more data
100 Deals associated with EN3285
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous cell carcinoma of the oral cavityPhase 3
United States
Endo Pharmaceuticals, Inc.
01 Dec 2007
StomatitisPhase 3
United States
Endo Pharmaceuticals, Inc.
01 Dec 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free